Nath Bio-Genes (India) Ltd. (IN:NATHBIOGEN)
:NATHBIOGEN
Want to see IN:NATHBIOGEN full AI Analyst Report?
NATHBIOGEN Stock Chart & Stats
₹158.80
-₹4.15(-2.25%)
At close: 4:00 PM EST
₹158.80
-₹4.15(-2.25%)
Day’s Range― - ―
52-Week Range₹126.75 - ₹238.00
Previous CloseN/A
Volume20.69K
Average Volume (3M)2.58K
Market Cap
₹3.26B
Enterprise Value₹3.91B
Total Cash (Recent Filing)₹1.59B
Total Debt (Recent Filing)₹1.55B
Price to Earnings (P/E)―
Beta1.18
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.26%
Share Statistics
EPS (TTM)21.68
Shares Outstanding19,004,000
10 Day Avg. Volume2,256
30 Day Avg. Volume2,581
Financial Highlights & Ratios
PEG Ratio1.86
Price to Book (P/B)0.38
Price to Sales (P/S)0.58
P/FCF Ratio-10.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetThe company's low debt-to-equity (~0.16–0.19) and steadily building equity indicate durable financial flexibility. Low leverage supports capital allocation for R&D, seasonal working capital, and weathering poor harvest cycles without forcing dilutive financing, preserving long-term strategic optionality.
Sustained ProfitabilityConsistent positive net and double-digit operating margins reflect underlying product pricing power and cost discipline in seed production. Sustained profitability supports reinvestment in breeding programs, margin resilience across cycles, and the ability to fund distribution and channel development over multiple seasons.
Improving Revenue TrendA rebound in revenue growth suggests improving product adoption or market share recovery. For a seed company, accelerating top-line supports scale in production, better utilization of processing assets, and stronger bargaining with distributors, which can sustainably lift earnings over ensuing planting seasons.
Bears Say
Weak Cash GenerationNegative operating and free cash flow despite accounting profits signals weak cash conversion, likely from working-capital swings or timing of collections/payments. This reduces near-term self-funding for seed production cycles, increases reliance on external financing, and raises execution risk across seasons.
Margin CompressionA material fall in net margins from ~16% to ~9% indicates pricing pressure, rising input or processing costs, or unfavorable product mix shifts. Sustained compression undermines free cash generation and limits scope for reinvestment in breeding and distribution, weakening long-term competitive positioning.
Earnings Volatility / Historical LossA prior sharp loss and only moderate ROE (~6%) show earnings volatility tied to crop cycles, R&D outcomes, or execution. Structural volatility makes forecasting adoption of new hybrids harder and increases the risk premium for longer-term commitments from dealers and investors, constraining growth plans.
Nath Bio-Genes (India) Ltd. News
NATHBIOGEN FAQ
What was Nath Bio-Genes (India) Ltd.’s price range in the past 12 months?
Nath Bio-Genes (India) Ltd. lowest stock price was ₹126.75 and its highest was ₹238.00 in the past 12 months.
What is Nath Bio-Genes (India) Ltd.’s market cap?
Nath Bio-Genes (India) Ltd.’s market cap is ₹3.26B.
When is Nath Bio-Genes (India) Ltd.’s upcoming earnings report date?
Nath Bio-Genes (India) Ltd.’s upcoming earnings report date is Aug 06, 2026 which is in 74 days.
How were Nath Bio-Genes (India) Ltd.’s earnings last quarter?
Nath Bio-Genes (India) Ltd. released its earnings results on May 04, 2026. The company reported -₹0.79 earnings per share for the quarter, missing the consensus estimate of N/A by -₹0.79.
Is Nath Bio-Genes (India) Ltd. overvalued?
According to Wall Street analysts Nath Bio-Genes (India) Ltd.’s price is currently Overvalued.
Does Nath Bio-Genes (India) Ltd. pay dividends?
Nath Bio-Genes (India) Ltd. pays a Notavailable dividend of ₹2 which represents an annual dividend yield of 1.26%. See more information on Nath Bio-Genes (India) Ltd. dividends here
What is Nath Bio-Genes (India) Ltd.’s EPS estimate?
Nath Bio-Genes (India) Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nath Bio-Genes (India) Ltd. have?
Nath Bio-Genes (India) Ltd. has 19,004,000 shares outstanding.
What happened to Nath Bio-Genes (India) Ltd.’s price movement after its last earnings report?
Nath Bio-Genes (India) Ltd. reported an EPS of -₹0.79 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.393%.
Which hedge fund is a major shareholder of Nath Bio-Genes (India) Ltd.?
Currently, no hedge funds are holding shares in IN:NATHBIOGEN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nath Bio-Genes (India) Ltd.
Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers seeds for cereals, such as maize, paddy, millet, wheat, and jowar; fruit seeds; fiber and oil seeds, including cotton and mustard; and seeds for vegetables comprising chilli, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, onion, sweet peeper, green paeas, pumpkin, tinda, cabbage, and French beans. It also provides crop protection supplements, such as WINPro GOLii, WINall, and Win Chi Win growth enhancer; and forage supplements, including NUTRIMAX GOLD and NUTRIMAX for enhanced fodder yields. The company offers its products through a network of distributors, dealers, and processing plants. Nath Bio-Genes (India) Limited was founded in 1979 and is based in Aurangabad, India.
Technical Analysis
Dhanuka Agritech Limited
―
Insecticides (India) Limited
―
India Pesticides Ltd.
―
Rallis India Limited
―
Sharda Cropchem Ltd.
―